Cancer Centers in the News

The following links highlight some of the most up-to-date news from the 25 NCCN Member Institutions. The media coverage below includes major national news outlets, industry magazines, medical journals, and press releases.

The news is listed in reverse chronological order for ease of use.

July 23, 2014
Top-Ranked Hospitals for Cancer – U.S. News and World Report

U.S. News and World Report has issued its list of the 50 top-ranked cancer hospitals in the United States. This list features a number of NCCN Member Institutions, including the top five:

  1. Memorial Sloan Kettering Cancer Center
  2. The University of Texas MD Anderson Cancer Center
  3. Mayo Clinic Cancer Center
  4. Dana-Farber/Brigham and Women’s Cancer Center
  5. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

 

>View Article<



July 18, 2014
“Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval,” Roswell Park Cancer Institute

The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute approval to begin genomic testing of cancer patients using its OmniSeq TargetTM advanced molecular diagnostic laboratory test.

Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions.

>View Article<



July 17, 2014
“Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site,” Huntsman Cancer Institute at the University of Utah

A team of physician-researchers from Huntsman Cancer Institute at the University of Utah will receive nearly $3.6 million over the next five years in a cooperative agreement with the National Institutes of Health (NIH) to establish a Network Lead Academic Participating Site (NLAPS). The award places HCI in an elite group of only 30 to 40 NLAPS locations nationwide; these sites are part of the NIH effort to create a new National Clinical Trials Network (NCTN).

Huntsman Cancer Institute at the University of Utah is one of the 25 NCCN Member Institutions.

>View Article<



July 15, 2014
“Game Theory” Model Reveals Vulnerable Moments for Metastatic Cancer Cells' Energy Production,” The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Cancer’s no game, but researchers at Johns Hopkins are borrowing ideas from evolutionary game theory to learn how cells cooperate within a tumor to gather energy. Their experiments, they say, could identify the ideal time to disrupt metastatic cancer cell cooperation and make a tumor more vulnerable to anti-cancer drugs.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of the 25 NCCN Member Institutions.

>View Article<



July 15, 2014
“Prostate Cancer in Young Men – More Frequent and More Aggressive?” University of Michigan Comprehensive Cancer Center

The number of younger men diagnosed with prostate cancer has increased nearly six-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis from researchers at the University of Michigan Comprehensive Cancer Center—one of the 25 NCCN Member Institutions.

>View Article<



July 14, 2014
“4 Lessons for Effective, Efficient Research in Health Care Settings,” University of Colorado Cancer Center

Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly. By taking into account the real-world constraints of the systems in which providers deliver care and patients receive it, researchers can help speed results, cut costs, and increase chances that recommendations from their findings will be implemented.

University of Colorado Cancer Center is one of the 25 NCCN Member Institutions.

>View Article<



June 27, 2014
“Study Points to Higher Risk of Breast Cancer Progression in Obese Women,” The University of Texas MD Anderson Cancer Center

A new study comparing obese mice with breast cancer and biological changes in breast cancer samples from patients appears to indicate the tie between obesity and higher risk for death.  By analyzing biopsy samples from 137 ER+ breast cancer patients before they received treatment, and developing an “obese” transgenic mouse model to study how tumors begin and grow, scientists at The University of Texas MD Anderson Cancer Center were able to show evidence for how obesity may cause some women to develop ER+ breast cancer more quickly – and with more deadly results.

The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions.

>View Article<



June 27, 2014
“Some Aggressive Cancers May Respond to Anti-inflammatory Drugs,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Studying triple-negative breast cancer, researchers at the Siteman Cancer Center and Washington University School of Medicine found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases.

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is one of the 25 NCCN Member Institutions.

>View Article<



June 26, 2014
“Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds,” Bloomberg

A recent study from Yale Cancer Center/Smilow Cancer Hospital found that Regular aspirin use cut the risk of pancreatic cancer by half, according to a finding that adds one of the most lethal malignancies to the list of diseases the inexpensive pill may help fight.

Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions.

>View Article<



June 25, 2014
“St. Jude Children's Research Hospital Names New CEO in Memphis,” Bloomberg Businessweek

With 28 years under his belt at St. Jude Children's Research Hospital and a global reputation for advancing the science and treatment of children with cancer, Dr. James R. Downing has a clear vision for where he wants to lead the Memphis institution as its new chief executive officer.

St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center is one of the 25 NCCN Member Institutions.

>View Article<



June 24, 2014
“Study Sheds Light on Racial Disparity in Colon Cancer,” University of Michigan Comprehensive Cancer Center

African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to die of colon cancer than Caucasians with the same stage of disease.

University of Michigan Comprehensive Cancer Center is one of the 25 NCCN Member Institutions.

>View Article<



June 24, 2014
“Mayo Clinic Researchers Say Gene in Brain Linked to Kidney Cancer,” Mayo Clinic Cancer Center

A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting. In this video, John A. Copland, PhD, molecular biologist and this study's senior investigator, discusses the findings of a recent study, which was published in Cancer Research.

Mayo Clinic Cancer Center is one of the 25 NCCN Member Institutions.

>View Article<



June 23, 2014
"BPA Stimulates Growth of Breast Cancer Cells, Diminishes Effect of Treatment," Duke Cancer Institute

Bisphenol A (BPA), a chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers presenting at an annual meeting of endocrine scientists.

Duke Cancer Institute is one of the 25 NCCN Member Institutions.

>View Article<



May 30, 2014
"Radiation for Prostate Cancer Linked to Secondary Cancers, Study Finds," University of Michigan Comprehensive Cancer Center

Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan Comprehensive Cancer Center—one of the 25 NCCN Member Institutions.

>View Article<



May 29, 2014
"Study Affirms Value of Epigenetic Test for Markers of Prostate Cancer," The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A multicenter team of researchers report that a commercial test designed to rule out the presence of genetic biomarkers of prostate cancer may be accurate enough to exclude the need for repeat prostate biopsies in many — if not most — men.

This study included researchers from The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins—one of the 25 NCCN Member Institutions.

>View Article<



May 28, 2014
"Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating," Moffitt Cancer Center

Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center –James Cancer Hospital and Solove Research Institute, announced Wednesday what is likely the largest collaboration of its kind to accelerate discoveries in cancer research.

Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute are two of the 25 NCCN Member Institutions.

>View Article<



May 27, 2014
"Intensity Modulated Proton Therapy Shows Benefit for Head and Neck Cancer," The University of Texas MD Anderson Cancer Center

In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment. Side effects typical of standard radiation were also reduced in some cases. These preliminary results suggest that proton therapy may be an effective and less toxic treatment option for patients with head and neck cancer.

The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions.

>View Article<